PMCC PMCC

Search tips
Search criteria

Advanced
Results 1-25 (94)
 

Clipboard (0)
None

Select a Filter Below

Year of Publication
more »
1.  PharmGKB summary: tramadol pathway 
Pharmacogenetics and genomics  2014;24(7):374-380.
doi:10.1097/FPC.0000000000000057
PMCID: PMC4100774  PMID: 24849324
analgesic; CYP2D6; OCT1; opioids; OPRM1; pathway; pharmacogenomics; pharmacokinetics; tramadol
2.  PharmGKB Summary: Efavirenz Pathway, Pharmacokinetics (PK) 
Pharmacogenetics and genomics  2015;25(7):363-376.
doi:10.1097/FPC.0000000000000145
PMCID: PMC4461466  PMID: 25966836
Efavirenz; CYP2B6; pharmacokinetics; pharmacogenetics
3.  PharmGKB summary: very important pharmacogene information for SLC22A1 
Pharmacogenetics and genomics  2014;24(6):324-328.
doi:10.1097/FPC.0000000000000048
PMCID: PMC4035531  PMID: 24681965
drug transport; OCT1; pharmacogenetics; pharmacogenomics; SLC22A1
4.  Very important pharmacogene summary for VDR 
Pharmacogenetics and genomics  2012;22(10):758-763.
doi:10.1097/FPC.0b013e328354455c
PMCID: PMC3678550  PMID: 22588316
drug response; genetic variants; pharmacogenomics; vitamin D receptor
5.  Cytochrome P450 2D6 
Pharmacogenetics and genomics  2009;19(7):559-562.
doi:10.1097/FPC.0b013e32832e0e97
PMCID: PMC4373606  PMID: 19512959
CYP2D6; pharmacogenetics; pharmacogenomics; PharmGKB; polymorphism; variant
6.  PharmGKB summary: ibuprofen pathways 
Pharmacogenetics and genomics  2015;25(2):96-106.
doi:10.1097/FPC.0000000000000113
PMCID: PMC4355401  PMID: 25502615
cyclooxygenase; CYP2C8; CYP2C9; ibuprofen; nonsteroidal anti-inflammatory drugs; pathway; pharmacogenomics; prostaglandins
7.  PharmGKB summary: very important pharmacogene information for CFTR 
Pharmacogenetics and genomics  2015;25(3):149-156.
doi:10.1097/FPC.0000000000000112
PMCID: PMC4336773  PMID: 25514096
CFTR; cystic fibrosis; pharmacogenetics; pharmacodynamics; ivacaftor; potentiator; corrector; modulator
8.  PharmGKB summary: mycophenolic acid pathway 
Pharmacogenetics and genomics  2014;24(1):73-79.
doi:10.1097/FPC.0000000000000010
PMCID: PMC4091813  PMID: 24220207
immunosuppressive agents; inosine monophosphate dehydrogenase; mycophenolate mofetil; mycophenolic acid; pharmacogenetics; pharmacogenomics
9.  PharmGKB summary: venlafaxine pathway 
Pharmacogenetics and genomics  2014;24(1):62-72.
doi:10.1097/FPC.0000000000000003
PMCID: PMC4098656  PMID: 24128936
CYP2C19; CYP2D6; pharmacogenetics; serotonin–norepinephrine reuptake inhibitor; venlafaxine
10.  PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8 
Pharmacogenetics and genomics  2013;23(12):721-728.
doi:10.1097/FPC.0b013e3283653b27
PMCID: PMC4038626  PMID: 23962911
CYP2C8; CYP2C8*3; metabolism; pharmacogenetics; pharmacogenomics; pharmGKB
11.  PharmGKB summary: tamoxifen pathway, pharmacokinetics 
Pharmacogenetics and genomics  2013;23(11):643-647.
doi:10.1097/FPC.0b013e3283656bc1
PMCID: PMC4084801  PMID: 23962908
breast cancer; pathway; pharmacogenomics; tamoxifen
12.  PharmGKB summary: Gemcitabine Pathway 
Pharmacogenetics and genomics  2014;24(11):564-574.
doi:10.1097/FPC.0000000000000086
PMCID: PMC4189987  PMID: 25162786
Gemcitabine; deoxycytidine analogs; pancreatic cancer; non-small cell lung cancer; breast cancer; pharmacogenomics
13.  Etoposide pathway 
Pharmacogenetics and genomics  2009;19(7):552-553.
doi:10.1097/FPC.0b013e32832e0e7f
PMCID: PMC4164627  PMID: 19512958
etoposide; pathway; pharmacogenetics; pharmacogenomics; pharmGKB
14.  Platinum pathway 
Pharmacogenetics and genomics  2009;19(7):563-564.
doi:10.1097/FPC.0b013e32832e0ed7
PMCID: PMC4153753  PMID: 19525887
anticancer; drug response; pathway; pharmacogenomics; platinum
15.  PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics 
Pharmacogenetics and genomics  2014;24(9):464-476.
doi:10.1097/FPC.0000000000000058
PMCID: PMC4122637  PMID: 24915143
Adverse drug reactions; allopurinol; rasburicase; uric acid; uricosurics; pharmacodynamics; pharmacogenetics
16.  PharmGKB summary: diuretics pathway, pharmacodynamics 
Pharmacogenetics and genomics  2013;23(8):449-453.
doi:10.1097/FPC.0b013e3283636822
PMCID: PMC4084786  PMID: 23788015
diuretics; hypertension; pathway; pharmacogenetic; pharmacogenomic
17.  PharmGKB Summary: Very Important Pharmacogene information for N-acetyltransferase 2 
Pharmacogenetics and genomics  2014;24(8):409-425.
doi:10.1097/FPC.0000000000000062
PMCID: PMC4109976  PMID: 24892773
Acetylation; acetylator; NAT1; NAT2; metabolism; pharmacokinetics; genotype; pharmacogenetics; drug toxicity
18.  PharmGKB summary: cyclosporine and tacrolimus pathways 
Pharmacogenetics and genomics  2013;23(10):563-585.
doi:10.1097/FPC.0b013e328364db84
PMCID: PMC4119065  PMID: 23922006
ABCB1; calcineurin; cyclosporine; CYP3A4; CYP3A5; pharmacodynamics; pharmacogenetics; pharmacokinetics; tacrolimus; transplantation
19.  PharmGKB summary: methylene blue pathway 
Pharmacogenetics and genomics  2013;23(9):498-508.
doi:10.1097/FPC.0b013e32836498f4
PMCID: PMC4091817  PMID: 23913015
glucose-6-phosphate dehydrogenase; hemolytic anemia; methemoglobinemia; methylene blue; reduced nicotinamide adenine dinucleotide phosphate; oxidative stress; pentose phosphate pathway; pharmacodynamics; pharmacogenetics; red blood cells
20.  PharmGKB summary: very important pharmacogene information for UGT1A1 
Pharmacogenetics and genomics  2014;24(3):177-183.
doi:10.1097/FPC.0000000000000024
PMCID: PMC4091838  PMID: 24492252
atazanavir; Crigler–Najjar syndrome; Gilbert’s syndrome; indinavir; irinotecan; pharmacogenetics; UGT1A1
21.  PharmGKB summary: abacavir pathway 
Pharmacogenetics and genomics  2014;24(5):276-282.
doi:10.1097/FPC.0000000000000040
PMCID: PMC4074515  PMID: 24625462
abacavir; HIV; HLA-B; HLA-B*57:01; HSP70-HOM; hypersensitivity; pharmacodynamics; pharmacogenetics; pharmacokinetics; PharmGKB
22.  Valproic acid pathway: pharmacokinetics and pharmacodynamics 
Pharmacogenetics and genomics  2013;23(4):236-241.
doi:10.1097/FPC.0b013e32835ea0b2
PMCID: PMC3696515  PMID: 23407051
pathway; pharmacodynamics; pharmacogenomics; pharmacokinetics; valproic acid
23.  PharmGKB Summary: Very Important Pharmacogene Information for Epidermal Growth Factor Receptor (EGFR) 
Pharmacogenetics and genomics  2013;23(11):636-642.
doi:10.1097/FPC.0b013e3283655091
PMCID: PMC3966564  PMID: 23962910
Epidermal growth factor receptor (EGFR); tyrosine kinase inhibitor; erlotinib; gefitinib; pharmacogenomics
24.  PharmGKB summary: zidovudine pathway 
Pharmacogenetics and genomics  2012;22(12):891-894.
doi:10.1097/FPC.0b013e32835879a8
PMCID: PMC3696524  PMID: 22960662
ABCC4; ABCB1; HIV infection; UGT2B7; zidovudine
25.  Metformin pathways: pharmacokinetics and pharmacodynamics 
Pharmacogenetics and genomics  2012;22(11):820-827.
doi:10.1097/FPC.0b013e3283559b22
PMCID: PMC3651676  PMID: 22722338
AMP-activated protein kinase; diabetes mellitus; metformin; multidrug and toxin extrusion 1; OCT1; OCT2; pathway; pharmacodynamics; pharmacogenomic; pharmacokinetics; type 2 diabetes

Results 1-25 (94)